Martine A. Rothblatt
Chairperson & CEO, Director · UNITED THERAPEUTICS Corp
- 2025
- Oct 13, 2026
- 179
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Martine A. Rothblatt files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- James Edgemond - $201.52M in UTHR purchases and sales in the last 12 months
- Michael Benkowitz - $135.23M in UTHR purchases and sales in the last 12 months
- Paul A. Mahon - $98.96M in UTHR purchases and sales in the last 12 months
- Christopher Patusky - $2.73M in UTHR purchases and sales in the last 12 months
- Ray Kurzweil - $2.40M in UTHR purchases and sales in the last 12 months
- Tommy G. Thompson - $2.06M in UTHR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Martine A. Rothblatt?
Martine A. Rothblatt is a corporate insider, tracked as Chairperson & CEO, Director of UNITED THERAPEUTICS Corp (UTHR). InsiderAlpha holds 179 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Martine A. Rothblatt submitted recently?
60 primary Form 4 filings in the last 90 days, covering 1 company.
Has Martine A. Rothblatt been buying or selling stock?
Recorded transactions: 1 open-market purchase ($864K) and 1800 open-market sales ($846.50M) across all tracked filings.
